Cigna Group (CI): debt financing — Cigna issues $4.5B in senior notes across four tranches to fund tender offers and refinancing

Cigna Group

Issued $1.0B 5.000% notes due 2029, $750M 5.125% notes due 2031, $1.25B 5.250% notes due 2034, $1.5B 5.600% notes due 2054.
Proceeds will fund tender offers for up to $2.25B of outstanding notes maturing 2024-2030.
Remaining proceeds to repay 0.613% Senior Notes due March 2024 and for general corporate purposes including share repurchases.

item 1.01 item 2.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cigna Group incurred senior notes of $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034 with U.S. Bank Trust Company, National Association at 5.250% maturing due 2034.

Instrument: senior notes
Principal: $1.25 billion in aggregate principal amount of its 5.250% Senior Notes due 2034
Counterparty: U.S. Bank Trust Company, National Association
Rate: 5.250%
Maturity: due 2034
Event: incurrence

Exact text from the filing

Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cigna Group incurred senior notes of $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054 with U.S. Bank Trust Company, National Association at 5.600% maturing due 2054.

Instrument: senior notes
Principal: $1.5 billion in aggregate principal amount of its 5.600% Senior Notes due 2054
Counterparty: U.S. Bank Trust Company, National Association
Rate: 5.600%
Maturity: due 2054
Event: incurrence

Exact text from the filing

Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cigna Group incurred senior notes of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029 with U.S. Bank Trust Company, National Association at 5.000% maturing due 2029.

Instrument: senior notes
Principal: $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029
Counterparty: U.S. Bank Trust Company, National Association
Rate: 5.000%
Maturity: due 2029
Event: incurrence

Exact text from the filing

On February 13, 2024, The Cigna Group (the “Company” or “our”) completed its previously announced offering of $1.0 billion in aggregate principal amount of its 5.000% Senior Notes due 2029

View on SEC.gov

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Cigna Group incurred senior notes of $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031 with U.S. Bank Trust Company, National Association at 5.125% maturing due 2031.

Instrument: senior notes
Principal: $750 million in aggregate principal amount of its 5.125% Senior Notes due 2031
Counterparty: U.S. Bank Trust Company, National Association
Rate: 5.125%
Maturity: due 2031
Event: incurrence

Exact text from the filing

Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Cigna Group entered into Supplemental Indenture No. 7 with U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (effective 2024-02-13).

Action: entry
Agreement: notes offering
Counterparty: U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee
Effective: 2024-02-13

Exact text from the filing

The terms of the Notes are governed by an Indenture, dated as of September 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as successor to U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by Supplemental Indenture No. 7 to the Base Indenture, dated as of February 13, 2024 (“Supplemental Indenture No. 7”), between the Company and the Trustee.

View on SEC.gov

299 debt financings filed in the last 30 days. Browse all debt financings →

Cigna Group filing history →

Source: SEC EDGAR

accession 0001140361-24-007429

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.